Legal
Key facts
Hagens Berman Sobol Shapiro LLP says a securities class action lawsuit has been filed involving Regeneron…
Key facts
The company identified is Regeneron Pharmaceuticals, Inc., NASDAQ ticker REGN
Key facts
The litigation concerns a Phase 3 clinical trial of fianlimab in combination with Libtayo for first-line…
Atlas Watchline
Hagens Berman says investors can join a proposed class action tied to Regeneron’s fianlimab and Libtayo…